Can vaccines keep breast cancer away? new study tests two options

NCT ID NCT03384914

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two different vaccines designed to prevent HER-2 positive breast cancer from coming back in people who have already completed initial treatment. About 119 participants who had surgery after chemotherapy will receive one of the two vaccines, followed by booster shots. The main goals are to check the vaccines' safety and see if they can delay or stop the cancer from returning.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Emory - Winship Cancer Institute

    Atlanta, Georgia, 30322, United States

  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, 33612, United States

  • Indiana University - Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana, 46202, United States

  • Ohio State University - Arthur G James Cancer Hospital & Richard J Solove Research Institute

    Columbus, Ohio, 43210, United States

  • Roswell Park Comprehensive Cancer Center

    Buffalo, New York, 14263, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08903, United States

  • University of Washington, Fred Hutchinson Cancer Research Center

    Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.